Spero Therapeutics, Inc. Proceeds from Royalties Received
Spero Therapeutics, Inc. (SPRO) reported Proceeds from Royalties Received of $50.00 million for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-16.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRoyaltiesReceived · last filed 2022-05-16
- Spero Therapeutics, Inc. proceeds from royalties received for the quarter ending 2022-03-31 was $50.00M.
- Spero Therapeutics, Inc. proceeds from royalties received for fiscal 2021 was $50.00M.
| Period end | Proceeds from Royalties Received 3 month | Proceeds from Royalties Received 12 month |
|---|---|---|
| 2022-03-31 | $50.00M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $50.00M 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 |